Accendra Health, Inc.
NYSE:ACH · New York Stock Exchange
+$0.12 today
Vol 0.90M · Avg 0.83M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-55.63%
Period High
$9.42
Period Low
$1.91
Latest
$3.23
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
BioAge Labs, Inc.
NASDAQ:BIOA
$778.07M
Aclaris Therapeutics, Inc.
NASDAQ:ACRS
$535.44M
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$490.18M
Cabaletta Bio, Inc.
NASDAQ:CABA
$470.41M
Canopy Growth Corporation
NASDAQ:CGC
$405.86M
Sight Sciences, Inc.
NASDAQ:SGHT
$280.21M
Editas Medicine, Inc.
NASDAQ:EDIT
$256.99M
High Tide Inc.
NASDAQ:HITI
$204.73M
CVRx, Inc.
NASDAQ:CVRX
$131.62M
Outset Medical, Inc.
NASDAQ:OM
$87.03M
What is the latest ACH filing?
The latest filing shown is 8-K dated Jun 15, 2026.
How many recent filings does ACH have?
Intrinsic Alpha currently shows 20 recent filings for ACH.
Explore More
Continue the stock analysis
Jump to another research area for this company.